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Adeno-associated virus (AAV) is a classification given to a group of nonpathogenic, single-stranded DNA
viruses known to reside latently in primates. During latency in humans, AAV type 2 (AAV2) preferentially in-
tegrates at a site on chromosome 19q13.3ter by targeting a sequence composed of an AAV Rep binding element
(RBE), a spacer, and a nicking site. Here, we report the DNA sequence of an African green monkey AAV in-
tegration site isolated from CV-1 cells. Overall, it has 98% homology to the analogous human site, including
identical spacer and nicking sequences. However, the simian RBE is expanded, having five perfect directly
repeated GAGC tetramers. We carried out a number of in vitro and in vivo assays to determine the effect of this
expanded RBE sequence on the Rep-RBE interaction and AAV targeted integration. Using electromobility shift
assays it was demonstrated that AAV4 Rep68 bound the expanded RBE with a sixfold-greater affinity than the
human RBE. To determine the basis for the affinity increase, DNase I protection and methylation interference
(MI) assays were performed. Comparison of footprints on both the human and simian RBEs revealed nearly
identical protection; however, MI analysis suggested greater interaction with the guanine nucleotides of the
expanded RBE, thus providing a biochemical basis for the increased binding activity. In vivo, integration
targeted to the simian RBE was demonstrated by PCR analysis of latently infected Cos-7 cells. Interestingly,
the frequency of site-specific integration was twofold greater in Cos-7 cells than in HeLa cells. Overall, these
experiments establish that the simian RBE, identified in CV-1 cells, functions analogously to the human RBE
and provide further evidence for a developing model that proposes individual roles for the RBE and the spacer
and nicking site elements.
To date, eight different but closely related adeno-associated
virus (AAV) serotypes (types 1 to 8) which infect primates
have been identified (reviewed in references 6 and 16). These
viruses are members of the family Parvoviridae, and they have
a unique biology that makes them particularly well suited as
gene therapy vectors (1, 6, 16, 35, 42–44). Additionally, AAV
(specifically type 2 [AAV2]) has been shown to be the only
known mammalian virus having the potential to site-specifi-
cally integrate into the human genome, preferentially targeting
a site on human chromosome 19q13.3qter (ch19) (6, 9, 20, 21,
25, 33, 34, 41)
The AAV genome is composed of linear single-stranded
DNA 4.7 kb long (42, 49), and while AAV2 is the most
thoroughly characterized AAV, studies of other serotypes are
under way (10, 12, 38). These include monkey-specific AAV4,
which was recently cloned and found to have a high degree of
homology to AAV2 (12). The AAV4 genome has two open
reading frames, like that of AAV2, and codes for similar Rep
proteins (Rep78 [78 kDa], -68, -52, and -40). For example, the
AAV4 Rep68 protein has 90% amino acid identity to AAV2
Rep68, with 5% of the divergent amino acids being similar in
hydrophobicity or structure (12). There is more divergence in
capsid proteins (Vp1, -2, and -3), with only 60% homology at
the amino acid level. In the inverted terminal repeats (ITRs),
similarity between the putative hairpin structures in the two
viruses is retained, but the AAV4 ITR sequences diverge at
two specific regions important in Rep binding. The AAV4 ITR
Rep binding element (RBE) is expanded, with four direct
GAGY tetramer repeats (GAGTGAGTGAGCGAGC), not
three perfect GAGC tetramers as seen in type 2 (12, 30).
Additionally, type 4 virus diverges at another possible Rep
contact site, the flip hairpin secondary structure, having a 5-
CTCTG-3 at the apex (12, 40). The exact importance of these
changes and their impact on the virus life cycle are still un-
known. However, the interaction of the AAV2 Rep proteins
with the RBE, spacer, and terminal resolution site (trs) of both
AAV2 and human ch19 has been previously characterized.
DNase I footprinting of type 2 Rep68 binding to linear AAV2
demonstrated protection of 32 nucleotides (nt), which included
the RBE, the 13-nt spacer, and the trs (11), and evidence of
Rep-specific interaction with nucleotides of these sites was
confirmed by chemical interference (40). Similar to the linear
ITR, DNase I footprinting of the ch19 site demonstrated 33 nt
(non-trs strand) protected by type 2 Rep68 (24). Additionally,
other studies suggest that stable binding is required for Rep to
be functionally active (8, 31). In vivo studies have determined
the biological importance of these sequences in targeting
AAV2 to ch19 (13, 14, 27, 28, 59). Therefore, it is not clear how
changes in these important sequences will affect targeted inte-
gration. Also, sequence divergence is not restricted to type 4
virus. The type 5 ITR has four direct GAGY repeats, one being
imperfect (GAGCCAGCGAGCGAGC). The trs of this sero-
type is also distinct, as is the spacer between the RBE and the
trs, which has an additional 5 nt. The impact of these sequence
changes on AAV replication has been measured by the inabil-
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ity of either type 2 or 5 Rep to cleave the other’s ITR substrate
(10). No studies have determined the impact of these divergent
ITR elements on site-specific integration.
Central to AAV2 site-specific integration is the presence of
these elements (RBE, spacer, and trs) on human ch19 (41, 50).
Not only are they present, but each component is required for
type 2 targeted integration (13, 14, 27, 28, 59). Similar to type
2 Rep cleavage activity, evidence for nicking and covalent
linkage on ch19 during targeted integration has been reported
(22, 23). Almost all experiments characterizing AAV latency
have been performed using the AAV2 serotype and human cell
lines (6, 13, 14, 20, 26, 28, 39, 48). Demonstration of AAV2
site-specific integration in nonhuman targets has generally em-
ployed “knock-in” animal models carrying the human ch19
sequences (39, 58). The biology of the monkey-specific AAV4,
with its expanded RBE, has not been thoroughly studied, nor
has the role of the simian chromosomal site-specific integra-
tion locus. Only Southern analysis, which demonstrated the
presence of sequences with homology to the ch19 targeting
locus in the monkey genome, has been carried out (45). To date,
no information about the suitability of this sequence for AAV
site-specific integration has been obtained. With the known di-
vergence of the type 4 ITR, it was of specific interest to determine
the exact sequence present in the monkey genome and, more
importantly, to test the abilities of these elements to carry out
site-specific integration as seen with type 2 in human cells.
In this report, we have identified an AAV integration locus
in CV-1 cells from the African green monkey and character-
ized its interaction with the AAV4 Rep68 protein. The AAV4
integration site has perfect homology to the human trs and
spacer; however, the simian RBE diverges, adding two addi-
tional GAGC tetramer repeats, creating five perfect direct
repeats. We constructed an AAV4 Rep68-histidine fusion pro-
tein (AAV4 Rep68H) and demonstrate that this protein will
specifically bind the simian RBE with a sixfold increase in
affinity compared to the human RBE. Analysis of binding by
methylation interference (MI) suggested that the increase is
due in part to specific interaction of Rep68H with the extra
guanine (G) nucleotides of the expanded RBE, as well as an
increased interaction overall. Electron microscopy (EM) anal-
ysis demonstrated sequence-specific protein-DNA complexes
indistinguishable from those generated using type 2 Rep and
human DNA substrates. These in vitro studies were followed
up by in vivo analysis, which demonstrated AAV site-specific
integration into the simian Cos-7 cells, establishing that the
simian RBE, spacer, and trs function analogously to the human
ch19 integration locus. It is interesting that we consistently
observed integration frequencies in Cos-7 cells that were two-
fold greater than those in HeLa cells. Although further studies
are required to rule out the potential roles of additional
genomic elements, variability in type 2 and type 4 Rep pro-
teins, or host proteins that may influence targeted integration,
the expanded simian RBE was the only obvious difference.
Overall, these results establish AAV site-specific integration
in the African green monkey and are consistent with previ-
ous studies that determined that the RBE, spacer, and trs
DNA elements individually influence site-specific integra-
tion.
MATERIALS AND METHODS
Plasmids. pRE2 contains a 2.7-kb fragment from human ch19 (45). pStump68
contains the gene for AAV2 Rep68 protein (45). pHIV68 contains the AAV2
Rep68 gene (56). pDD-neo, pDD-puro, and pDD-GFP (56) contain the neomy-
cin resistance gene, the puromycin resistance gene, and the green fluorescent
protein (GFP) gene, respectively, and all contain the AAV2 ITR sequences.
Cloning the African green monkey AAV integration site. pMkRBE contains
the RBE, spacer, and trs from the African green monkey genome. The plasmid
was constructed by TA cloning a PCR-amplified fragment (302 bp) from CV-1
cells into pCR2.1 (Invitrogen). CV-1 cells were maintained in Dulbecco’s mod-
ified Eagle’s medium (DMEM) supplemented with 10% fetal calf serum and
penicillin-streptomycin. PCR was performed as described by the manufacturer
with TaKaRa Ex Taq (PanVera Corp.) and 100 ng of CV-1 genomic DNA in a
standard reaction mixture supplemented with 30 mM MgCl2 and deaza-dCTP.
Temperature cycling consisted of 2 cycles of 97°C for 30 s, 58°C for 30 s, and 72°C
for 1.2 min, 35 cycles of 94°C for 1 min, 58°C for 30 s, and 72°C for 1 min, and
1 cycle of 94°C for 1 min, 58°C for 30 s, and 72°C for 7 min. PCR was performed
initially with the primers 5-GACATCGCACCGCCCGCCCG-3 and 5-TACT
TACTTACTTACCC-3. Then a second round of PCR was performed with the
primers 5-GACATCGCACCGCCCGCCCG-3 and 5-TGACTTCAGGCGTC
GA-3. The clones were sequenced at the University of North Carolina (UNC)
Sequencing Facility.
Viral propagation and purification. AAV4 was purchased from the American
Type Culture Collection and amplified in Cos-7 cells as previously described
(12). The Cos-7 cells were maintained in DMEM supplemented with 10% fetal
calf serum and penicillin-streptomycin. The cells were grown at 37oC in a 5%
CO2 humidified environment. The virus was purified using a cesium chloride
(CsCl2) gradient, and titers were determined by dot blotting (3).
AAV4 Rep68H protein production. AAV4 pRep68H contains the gene for the
AAV4 Rep68 protein inserted into pQE-70 (Qiagen). This vector places a
six-histidine tag on the C terminus of the protein. To clone the AAV4 Rep68
gene, PCR was performed using Takara Ex Taq polymerase in a standard reac-
tion mixture containing AAV4 genomic DNA (100 ng) with the oligonucleotides
5-TCTATCTAGACTTGGCCACTCCCTCTCTGCGCGC-3 and 5-AGGC
CTTAAGAGCAGTCGTCCACCACCTTGTTCC-3. The unspliced gene was
then digested with SphI and BglII (all restriction enzymes were purchased from
New England BioLabs) and ligated into pQE70 according to the manufacturer’s
instructions. To construct the intron minus AAV4 Rep68H, the clone was di-
gested with AatII and BglII and ligated to the correctly spliced C-terminal




The AAV4 Rep68H gene was sequenced at the UNC Sequencing Facility. The
amino acid sequence was wild type except for the six C-terminal histidines and a
proline-to-alanine change at amino acid 536. The AAV4 and AAV2 Rep68H
proteins were expressed and purified from SG13009 (Qiagen) as previously
described (58).
EMSAs. Competition electromobility shift assays (EMSAs) were performed as
previously described (31). Briefly, DNA substrates (200 bp) were made by di-
gesting pMkRBE with the restriction enzymes HindIII-AatII and digesting pRE2
with PvuII-AatII; then, the fragments were gel purified following standard pro-
cedures (3). For experiments using synthetic DNA as the substrate, oligonucle-
otides (41 bp) were annealed. Rep68H (1 pmol) was placed in a 20-l binding
reaction mixture containing cold competitor DNA, 10 mM HEPES-KOH [pH
7.5], 8 mM MgCl2, 40 mM KCl, 0.2 mM dithiothreitol, 8% glycerol, and 0.1 g
of poly(dI-dC)/l. Next, a [-32P]ATP end-labeled DNA substrate (6,000 cpm)
was added, and the reaction mixture was incubated for 20 min. Separation was
done at 90 V for 1 to 2 h using nondenaturing 4% polyacrylamide gel electro-
phoresis (PAGE). The free and bound fractions were quantified using a Phos-
phorImager (Molecular Dynamics).
DNase I protection assay. Protection assays were performed as previously
described (3, 31). Briefly, DNA substrates were made by restriction enzyme
digestion of pMkRBE and pRE2 with BspE1-DraIII and BspE1-EcoRI, respec-
tively. Rep68H (15 pmol) was incubated with the [-32P]ATP end-labeled DNA
substrate (50,000 cpm) in the EMSA binding buffer for 20 min at room temper-
ature. Then, DNase I (diluted to 0.5 U/l) was added and allowed to hydrolyze
the DNA for 30 to 60 s at room temperature. The sample was separated using
10% denaturing PAGE and run at 1,600 V for approximately 1 h, and then the
gel was exposed to film (Kodak).
MI. For the MI assay, 300-bp substrates were produced by restriction enzyme
digestion of pMkRBE and pRE2 with BspE1-AatII and BspE1-AccI, respectively.
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MI assays were performed as previously described (3, 40). Briefly, after being
[-32P]ATP end labeled, the substrate was treated with dimethyl sulfate (Sigma).
The Rep protein was incubated with the methylated substrate (100,000 cpm) and
electrophoresed as in the EMSA protocol. The free and bound fractions were gel
purified (3); then, Maxam-Gilbert chemical sequencing was performed (3). The
bands were quantified using a PhosphorImager, and the relative band intensity
ratio for each G residue was plotted as previously described (40).
EM. EM analysis was performed at the UNC EM Core Facility as described
previously (58). Purified AAV4 Rep68H was incubated with a 2.2- or 2.3-kb
DNA fragment containing the African green monkey or human ch19 RBE,
respectively. The binding reaction used a 1:1 mass ratio of protein-DNA, and the
conditions for binding were the same as for the EMSA.
Detection of latent AAV. Cos-7 and HeLa cells were transfected with either
pDD-neo, pDD-puro, or pDD-GFP alone or with AAV4 or AAV2 pHIVRep68
using Superfect reagent (Qiagen). All cells were maintained in DMEM sup-
plemented with 10% fetal calf serum and penicillin-streptomycin. Colonies
transfected with either pDD-neo or pDD-puro were selected with G418 and
puromycin, respectively (3, 56). After selection, genomic DNA was extracted fol-
lowing standard protocols (3). For GFP-expressing cells, a modular flow cytom-
eter (MoFlo; Cytomation Inc.) at the UNC Flow Cytometer Facility was used to
detect fluorescence and to place GFP-expressing cells into individual wells. To
demonstrate the presence of latent AAV, 100 ng of the DNA was analyzed by
PCR as previously described (52). Briefly, Deep Vent Exo() polymerase (New
England Biolabs) and the primers 5-CGGGGAGGATCCGCTCAGAGGA
CA-3 and 5-CGGCCTCAGTGAGCGAGCGAGC-3 were used along with
genomic DNA in standard PCR. The temperature cycle was 99°C for 1 min,
followed by 35 cycles of 99°C for 10 s and 72°C for 4 min. A fraction of the PCR
product was blotted and probed with a ch19 probe. As a negative control, each
primer was run separately in a reaction with genomic DNA to quantify the
background signal. Colonies were positive for integrated AAV if a signal greater
than that of background was obtained for the PCR (53).
RESULTS
Identification of an AAV integration site in CV-1 cells from
African green monkeys. To isolate the simian AAV integration
site, primers were designed using the human ch19 sequence
and PCRs were carried out with genomic DNA from CV-1
cells (an African green monkey kidney cell line). The PCR
consistently amplified a 302-bp fragment. Sequencing and
alignment revealed significant homology to the AAV integra-
tion locus of human ch19 (Fig. 1). Seven independent clones
were sequenced and aligned, all of which were identical, sug-
gesting accurate amplification of the simian DNA. Overall, the
cloned sequence demonstrated 98% identity between the hu-
man and African green monkey sequences, and excluding the
RBE, the divergent nucleotides occurred randomly throughout
the cloned fragment. At the Rep binding site, the simian DNA
has perfect homology to the human ch19 trs and spacer. How-
ever, the simian RBE diverges in length from the analogous
human sequence by having two additional GAGC tetramers,
creating five perfect direct repeats. The identification of nearly
identical genomic sequences carrying the RBE, spacer, and trs
in CV-1 cells made it reasonable to expect that AAV4 recom-
bination would be directed to this site. Since previous studies
had determined that the repeating GAGY motif of the RBE
was important for Rep binding, we carried out a series of ex-
periments to determine the role of the expanded simian motif.
Characterization of AAV4 Rep68H binding to the simian
target sequence. To investigate the interaction of AAV4
Rep68H with the simian RBE, DNase I protection assays
were performed. In reciprocal experiments, AAV4 or AAV2
Rep68H protein was incubated with either the simian or the
human ch19 AAV integration sequence (non-trs strand). The
results (Fig. 2A) demonstrated that the proteins produced
nearly identical protection patterns on either substrate. Both
the AAV4 and AAV2 Rep68H proteins protected approxi-
mately 33 to 34 nt of the expanded sequence, beginning 2 nt
downstream of the first GAGC repeat and extending to 1 bp
upstream of the nicking site complement. Evaluation of bind-
ing to the human RBE produced similar results, with protec-
tion extending 33 nt and including the RBE, spacer, and trs
sequences (summarized in Fig. 2B). For the AAV2 protein,
bound to the human RBE, the footprinting results are consis-
tent with previously reported data (24).
To further characterize the interactions between the Rep
FIG. 1. Sequence alignment of the AAV integration site from human ch19 and the 302-bp DNA fragment identified in the African green
monkey genome (Monkey) as cloned from CV-1 cells (Vector NTI software; InforMax). The three elements of the AAV integration locus, the
RBE, spacer, and trs, are underlined. The human ch19 RBE has three direct GAGC tetramers (dark shading), while the simian RBE is expanded,
having two additional GAGC tetramers (light shading). The simian trs is also darkly shaded, and an 8-bp spacer is located between this element
and the simian RBE, just as in the human ch19. Sequence homology is indicated by dots, dashes represent gaps in the sequence, and nonconsensus
bases for the monkey sequence are given (bottom line).
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proteins and their respective binding sites, we used EM to
visualize AAV4 Rep68H binding to both the simian RBE and
the human ch19 RBE. The AAV4 Rep68H protein was added
to a binding buffer containing either a 2.2-kb DNA fragment
with the simian RBE located approximately 400 bases from
one end or a 2.3-kb DNA fragment containing the human ch19
RBE located approximately 800 bases from one end (Fig. 3A
and B, respectively). The AAV4 Rep68H protein bound both
the simian and human fragments (Fig. 3) in a location consis-
tent with an RBE-specific interaction and formed Rep-DNA
complexes seemingly identical in size and conformation to
each other and to those previously described for type 2 Rep
binding human ch19 RBE (58). At a 1:10 molar ratio (DNA-
protein), 70% (16 of 23 molecules) of the fragments had
single AAV4 Rep68H bound to the simian RBE. All of the
remaining 30% (7 of 23 molecules analyzed) had multiple Rep
proteins, generally two, with one Rep complex binding the
RBE and another bound nonspecifically to the DNA and not in
FIG. 2. (A) Reciprocal DNase I protection analysis of AAV2 and AAV4 Rep68H proteins on the human ch19 and African green monkey DNA
substrates containing the RBE (underlined), spacer, and trs complement (underlined). The [-32P]ATP end-labeled substrate (non-trs strand) was
incubated with 15 pmol of Rep before DNase I digestion and denaturing PAGE analysis. For lanes GA, substrate DNA was chemically
sequenced using formic acid. For lanes Substrate, substrate DNA was treated with DNase I without any addition of Rep. (B) DNase I results are
summarized for human (top) and simian (bottom) sequences. The bar indicates the bases fully protected by both AAV2 and AAV4 Rep68H
proteins. The RBE and nicking site are both underlined.
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contact with the RBE-bound Rep. Similar results were ob-
served for the AAV4 Rep68H protein bound to the human
ch19 RBE (data not shown).
The results of the footprinting experiments and EM analysis
demonstrate that the AAV4 Rep68H protein binds specifically
and protects the simian RBE, spacer, and trs, suggesting that
these sequences carry all of the cis-acting elements necessary
to direct targeted integration of AAV4 in cells derived from
the African green monkey.
Rep68H relative affinity to human and simian chromosomal
DNAs. Next, we determined the relative affinities of the pro-
teins to the human and simian RBEs by performing competi-
tive EMSAs. The 302-bp fragment containing the simian RBE
was [-32P]ATP end labeled, and the binding of either AAV2
or AAV4 Rep68H to this substrate was competed away by cold
(either the simian or human RBE) competitor DNA (Fig. 4A).
In these reciprocal assays, the concentrations of Rep68H pro-
teins and the lengths of the DNA fragments, for the substrate
and competitor, were held constant. In addition, to accurately
compare affinities, the competition curve was performed over
a broad range of cold-competitor concentrations. Using this
range, we could perturb binding to the labeled DNA only
slightly or completely abolish it, providing an accurate deter-
mination of the relative equilibrium dissociation constants (15,
46). The AAV4 and AAV2 Rep68H proteins demonstrated a
6- and 10-fold increase in relative binding affinity, respectively,
for the simian RBE compared to the human RBE (Fig. 4B). To
further explore the possibility that the increased affinity was
due to a greater number of tetramer repeats, EMSA experi-
ments were conducted using synthetic DNA substrates. For
these, the AAV2 Rep68 protein was used to bind substrates
containing either three (3), four (4), five (5), or seven
(7) direct repeats of the GAGC tetramer. The results are
represented graphically in Fig. 4C and suggest that relative
affinity increases as the number of repeats increases, up to five
tetramers. At that point, the relative affinities of Rep for the
5 and 7 substrates were essentially equivalent (Table 1). The
fivefold increase in relative affinity of the AAV2 Rep protein
binding the 5 versus the 3 substrate was less than the 10-fold
increase demonstrated above. This may be due to the short frag-
ment length (41 bp) of the synthetic DNA substrates destabilizing
binding. For both experiments, however, the basis for the in-
crease in affinity for substrates having a greater number of
tetarmers was not apparent, considering that the simian and
human substrates produced nearly identical footprints. Next,
we compared the base-specific interactions of the Rep proteins
on the human ch19 and the simian DNA counterpart.
Methylation interference analysis of AAV4 Rep68H binding.
To determine a possible chemical basis for the increase in
affinity toward the expanded simian RBE, MI assays were
performed. AAV2 Rep68 is known to interact strongly with G
nucleotides of the human RBE (32, 40), and we suspected that
the expanded GAGC motif of the simian RBE was contribut-
ing to the increased binding affinity. The MI assays were done
as previously described, using dimethyl sulfate to methylate the
non-trs strand of the linear Rep binding site (32, 40). The
intensity of each band was quantified by PhosphorImager anal-
ysis, and the free:bound ratio was plotted for each G residue of
the sequence. A free/bound ratio of 1 indicates that the inter-
action of Rep with the particular G nucleotide contributes
little to binding, while an interaction of 1 indicates that the G
nucleotide contributes to binding (40). In reciprocal assays, we
evaluated the interactions of AAV4 and AAV2 Rep68H pro-
teins with either the methylated human or simian DNA (Fig.
5A). The results indicated that the interactions of both pro-
teins with the expanded RBE were quantitatively stronger than
with the human RBE. These results were consistent with the
assays described above and demonstrate that both Rep pro-
teins interacted with G residues within the DNase I protected
region (Fig. 5B). At the repeating GAGC motif, both proteins
produced symmetrical interaction patterns centered approxi-
mately at the middle tetramer, as previously described for
AAV2 Rep68 binding (40). However, this pattern was slightly
distorted for AAV2 Rep68H binding to the simian RBE. In-
terestingly, for any single G nucleotide, the greatest interaction
for both proteins was at the single GAGC tetramer within the
spacer region. Overall, the pattern produced by the interaction
of both the AAV2 and AAV4 Rep68H proteins with the meth-
ylated substrates suggests that the additional G residues of the
monkey RBE contribute to the greater affinity of both proteins
for the simian RBE.
FIG. 3. EM analysis of AAV4 Rep68H binding to the AAV site-specific integration loci from African green monkeys (A) and human ch19 (B).
The simian fragment was 2.2 kb long and contained the 302-bp simian site from CV-1 cells, with the expanded simian RBE located 0.4 kb from
one terminus. The human ch19 DNA fragment was 2.3 kb in length, with the RBE located 0.8 kb from one terminus. For both substrates, the AAV4
Rep68H protein covered an average of 60 bp as previously reported (58).
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Site-specific integration in Cos-7 cells. The above-men-
tioned in vitro studies were followed up by in vivo experiments
that demonstrated that the AAV4 Rep68 protein could medi-
ate site-specific integration in the simian genome. Cos-7 cells
were first cotransfected with AAV4 pHIV68 and pDD-neo (an
AAV substrate previously characterized for AAV site-specific
integration) (56, 59) and then selected for resistance to G418.
Colonies were examined by PCR for AAV site-specific recom-
bination at the simian RBE locus (53). As a negative control,
pDD-neo was transfected into Cos-7 cells without a source of
Rep protein. Each colony was tested in duplicate, and the
results demonstrated that 7 of 11 colonies (64%) were positive
FIG. 4. (A) Reciprocal competition EMSAs were performed to
determine the relative affinities of AAV4 Rep68H to the simian (left)
and human (right) DNA fragments. The African green monkey sub-
strate (200 bp) was [-32P]ATP end labeled and titrated with cold
competitor DNA (200 bp), either the simian fragment or the human
fragment, before the addition of the AAV4 Rep68H protein (1 pmol).
For lanes Rep, no Rep protein was added. Separate experiments
using the AAV2 Rep68H protein were conducted in an identical man-
ner. (B) After the bound and free fractions were quantified (using a
PhosphorImager), the bound fraction was graphed as a function of the
cold-competitor concentration, simian fragment (open squares) and
human fragment (solid squares). (C) Additionally, AAV2 Rep68 was
used in competition EMSAs with synthetic DNA as the substrate, and
the results were graphed. The synthetic substrates (41 bp) contained
either three (3), four (4), five (5), or seven (7) direct repeats of
the GAGC tetramer. The substrates and their relative affinities to cold
competitor 3 are given in Table 1. For all experiments, the compet-
itor concentrations required to achieve a 50% reduction in the fraction
bound were compared for each protein, and the relative binding af-
finity is the ratio of these competitor concentrations.
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for site-specific integration at the simian RBE locus (Fig. 6).
These results indicate that the RBE, spacer, and trs identified
in African green monkey cells are sufficient to direct site-
specific recombination.
Next, we compared the integration rates in Cos-7 and HeLa
cells after contransfection of the AAV2 Rep68 and AAV2 ITR
constructs pDD-puro and pDD-GFP. For the pDD-puro con-
struct, targeting was demonstrated after selection by PCR
analysis in 75 (12 of 16) and 42% (5 of 12) of the Cos-7 and
HeLa cells, respectively. For the GFP-expressing colonies, 3 to
5 days posttransfection the cells were enriched for GFP ex-
pression by sorting individual cells into wells using a MoFlo
cytometer. This created clonal colonies and corrected for any
difference in transfection efficiencies and growth rates between
the two cell lines. The cells were cultured continuously and
monitored for 4 months without selection. Both the Cos-7
and HeLa cells had approximately the same growth rate and
number of cells at confluence (data not shown). Initially, for
both cells lines, the percentage of cells expressing GFP de-
creased rapidly. By day 12 after sorting, the Cos-7 and HeLa
cells that received AAV2 Rep68 had a slightly higher percent-
age of cells positive for GFP expression. At day 105, the ex-
pression of GFP had been stable for 60 days, and the flow
cytometer was used again to determine the fraction of cells
expressing GFP. In the absence of AAV2 Rep68, only 0.4% of
Cos-7 and 0.6% of HeLa cells expressed stable GFP past 105
days. In contrast, 2.1% of the HeLa cells and 4.6% of the Cos-7
cells transfected with both AAV2 pHIV-Rep68 and pDD-GFP
were stable for GFP expression. The relationship between the
percentage of positive cells and time postsorting was graphed
(Fig. 7). These experiments suggested that the presence of
AAV2 Rep68 increased long-term stable expression of GFP in
both human and African green monkey cells and that latency
in Cos-7 cells was at least twofold greater than in HeLa cells.
PCR analysis for site-specific integration was performed on the
stable GFP-expressing cells (52). Our PCR results indicated
that in 80% of the Cos-7 clones, the GFP gene was being
expressed from the RBE locus, while none of the clones trans-
fected with only pDD-GFP targeted this site. For the HeLa
cells, 36% of the colonies expressed GFP from the simian RBE
locus. These studies support the observation that the chromo-
somal RBE, spacer, and trs DNA sequences direct AAV re-
combination to the site in both the human and simian genomes
and in addition suggest that the affinity and specificity of Rep
for the chromosomal RBE are directly related to the specific
integration rate.
DISCUSSION
In this study, we report the DNA sequence of an AAV
integration locus in the African green monkey genome. This is
the first time that a native RBE, spacer, and trs sequence other
than human has been identified and shown to support AAV
targeted recombination. Previously, a knock-in mouse con-
taining the human AAV integration locus on the mouse X
chromosome was developed independently by two different
laboratories (39, 58). The rodent models have a common over-
lapping human ch19 sequence of 1.6 kb that contains the RBE,
spacer, and trs sequences, which were shown to direct target-
ing to this locus on the X chromosome. These studies clearly
demonstrated that all necessary information required to sup-
port site-specific recombination was contained in the 1.6-kb
ch19 cis element.
Architectures of human and simian integration sites. In the
African green monkey, the spacer and trs sequences are iden-
tical to the human ch19 sequence. However, the simian RBE
has five rather than three direct repeats of the GAGC tet-
ramer. This expansion of the RBE sequences has also been
noted in the AAV4 ITR, where there are four rather than
three GAGY repeats, as seen in AAV2. The expansion of the
RBE sequence in both the simian chromosome and the AAV4
ITR suggests coevolution between virus and host. Although
the simian targeting locus and the type 4 viral ITR have di-
verged from their human counterparts (ch19 and the AAV2
ITR, respectively) with respect to the RBE, the spacer and trs
are conserved. The AAV2 and -4 ITRs, compared to the cor-
responding targeting loci (monkey and human ch19), contain
different spacer sequences (13 versus 8 nt, respectively). It is
not clear why both the human and monkey chromosomal loci
have 13-nt spacers while AAV2 and -4 have evolved to carry
only 8 nt. Surprisingly, AAV5, which was isolated from hu-
mans, has an 18-nt spacer which is distinct from those of all
other AAV ITRs and from those of the human and simian
chromosomal counterparts. Of the AAV serotypes, type 5 virus
is the only example where the spacing between the RBE and
trs is not conserved. In addition, Rep protein derived from
serotypes 1 to 4 will utilize all other AAV ITRs except type 5
ITR for replication substrates, and type 5 Rep is unable to
utilize type 1 through type 4 ITRs for replication (unpublished
observations and reference 10). These observations beg the
question of how the AAV origin evolved (human to virus or
virus to human) (8). In fact, using information concerning the
number of RBEs present in a serotype-specific ITR, one can
strongly suggest the species of origin. When we compared all of
the ITR sequences available (serotypes 1 to 7) against type 2
with the hope of identifying the origin of monkey versus human
isolates, type 5 appeared similar to type 4 in that the ITR also
carries an expanded repeat (10). If this is correct, type 5 maybe
the result of a nonhuman primate virus that jumped into hu-
mans. More importantly, the newly described types 6 and 7
have sequence identity to type 1 ITRs. This may represent
human isolates that have infected monkey colonies (16). Re-
cently, it was demonstrated that a viable nicking site on the
viral substrate is not necessary for site-specific recombination
(59). It will be interesting to determine if type 5 can carry out
targeted integration, as well as to determine what cis-acting
elements may be required. In addition, to these sequence dif-
ferences, we demonstrated that both AAV4 and AAV2
Rep68H proteins have greater affinity for the expanded RBE
that is at least in part due to the greater interaction with the
guanine bases of the added tetramers. We also documented
that the simian locus could serve as a suitable target for site-
specific integration in the monkey genome. Based on our in
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FIG. 5. (A) Reciprocal MI analysis of the AAV4 and AAV2 Rep68H proteins binding the human ch19 (left) and simian (right) sequences. The
substrates (non-trs strand) were [-32P] end labeled and methylated before being incubated with either of the Rep proteins (2 pmol). Then, the bound
and free fractions were purified and cleaved before separation by denaturing PAGE. For lanes Substrate, methylated substrate DNA was run without
any addition of the Rep protein. For lane GA, substrate DNA was chemically sequenced using formic acid. The long and short vertical lines next to
lanes Substrate indicate the GAGC tetramers and the trs location, respectively. Because of variable amounts of substrate in each lane, the con-
centration of substrate was normalized by quantification of bands outside the Rep binding site before graphical analysis. (B) MI graphical representa-
tion of AAV4 Rep68H and AAV2 Rep68H binding either the methylated simian substrate (solid bars) or the methylated human substrate (shaded
bars). The curved lines on the graph indicate symmetrical patterns produced by the interaction of the Rep proteins with the substrate. The se-
quences for the simian and human RBE, spacer, and trs are given beneath the graphs, and the GAGC tetramers are in boldface. F/B, free/bound ratio.
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vitro and in vivo data, the expansion of the simian chromo-
somal RBE did not hamper the type 2 targeting frequency and
may have influenced integration in a positive way (a twofold
increase in targeting in Cos-7 versus HeLa cells). Although not
specifically addressed in this study, it would be interesting to
determine if an expansion of the RBE in the AAV2 ITR, such
as occurs in AAV4, will also affect targeting. Elucidation of
these factors will contribute to clarifying the integration mech-
anism and the complex relationship between the AAV ITR
and chromosomal sequences.
Rep68-DNA stoichiometry. The AAV2 and AAV4 Rep68H
proteins demonstrated greater affinity for the expanded simian
RBE, and initially we presumed that a greater number of Rep
molecules may be binding the five directly repeating GAGC
tetramers. Recent studies, using a Rep protein mutated in the
multimerization domain, suggested that the ability of Rep to
form multimers is critical to its function (8, 22, 32, 53, 55). Rep
forms a multimeric protein complex when bound to the RBE,
spacer, and trs, and evidence for Rep78 forming dimeric to
hexameric structures on binding the AAV2 ITR has been re-
ported (36, 47). Our DNase I protection and EM data dem-
onstrated that the footprints Rep produced on binding either
FIG. 6. AAV4 Rep68 mediates the site-specific integration of an AAV2 ITR construct targeting the African green monkey RBE, spacer, and
trs in Cos-7 cells. The cells were cotransfected with AAV4 pHIV-Rep68 and pDD-neo and selected for G418 resistance before PCR analysis.
Primers ch19/AAV represent a PCR using one primer (ch19) that anneals to the simian genome and a second primer (AAV) that anneals to the
AAV2 ITR sequence. After PCR, the reaction product was blotted and hybridized to a ch19 probe. The AAV and ch19 primers were used alone
as negative controls in separate PCRs.
FIG. 7. Cos-7 and HeLa cells were cotransfected with pHIV-Rep68
and pDD-GFP and monitored for GFP expression for 105 days. Three
to 5 days posttransfection, GFP-expressing cells were sorted by fluo-
rescence-activated cell sorter into individual wells. Cells transfected
with pDD-GFP alone were also monitored. The data are graphed as
the fraction of green fluorescent cell colonies to the total number of
colonies as determined on different days.
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simian or human sequences were almost identical in size, sug-
gesting that the numbers of Rep molecules forming the protein
complex are equivalent. This is in agreement with our labora-
tories’ EM results, which suggested that equivalent numbers of
molecules form a Rep complex whether binding the AAV2
ITR, the human RBE, the simian RBE, or nonspecific DNA
(2, 57, 58). Previously, Ryan et al. examined Rep interaction
with mutated RBEs and suggested that the RBE, spacer, and
trs contain a single Rep recognition site (40). Together, the
data suggest that Rep does not regulate its action by forming
different multimeric protein structures at its various DNA
binding sites. Despite this, most investigators performing EM-
SAs on Rep-RBE interactions have noted the appearance of
multiple (generally three to six) bands or laddering in the
bound fraction. McCarty et al. suggested these bands corre-
sponded to either multiple DNA molecules bound to a single
Rep complex, multiple Rep complexes bound to a single DNA
molecule, or different numbers of Rep molecules forming the
Rep complex. Based on DNase I protection and EM data (2,
57, 58), a likely cause of this laddering, which occurs readily at
high concentrations of Rep, may be multiple Rep complexes
(with identical stoichiometries) binding a single DNA mole-
cule. Additionally, DNA conformation transitions, such as
bending or looping, may be occurring (15). Under certain
conditions, the presence of Rep-induced DNA bending can be
observed by EM analysis. It is unknown whether these DNA
conformation changes are artifacts or have some biological
significance (2, 57, 58). Protein-induced DNA bending is
known to be associated with many types of protein-DNA in-
teractions, including recombination, and additionally is known to
increase a protein’s binding affinity for DNA (15, 51). In the
case of Rep, an increase in binding affinity for the simian RBE
may positively relate to integration frequency in African green
monkey cells. It is also possible that the looping previously
observed by EM analysis (57, 58) affects AAV targeting by
altering Rep-ch19 interaction in some manner. We suspect
that these DNA conformational changes are Rep induced and
as such warrant further investigation.
Rep68-RBE interaction. In agreement with previous studies,
we demonstrated that Rep has greater affinity for substrates
with increased numbers of the GAGY tetramer (55). Our
competition EMSAs demonstrated that AAV4 and AAV2
Rep68H proteins have 6- and 10-fold-greater affinity, respec-
tively, for the expanded simian RBE than for the human ch19
RBE. Interestingly, we performed EMSAs with synthetic DNA
containing as many as seven copies of the GAGC tetramer and
determined that with more than five directly repeating tet-
ramer copies, the relative affinity does not significantly increase
(Fig. 4C). We believe that this result is due to the inability of
Rep to contact more than five GAGY tetramers in series, as
demonstrated by DNase I protection analysis, and its inability
to form protein complexes with variable stoichiometries. This
observation may indicate the importance of three, four, and
five direct repeats located in the type 2 and 4 viruses and the
simian targeting locus, respectively. It is of interest to note that
the AAV2 ITR and human ch19 retain similar numbers of
GAGY tetramers (three each), whereas the AAV4 ITR and
the simian targeting locus are different (four versus five, re-
spectively). Compared to humans, monkeys as a group are
evolutionarily more divergent from each other, and additional
sequence analysis of targeting loci from related and unrelated
primates, as well as ITR analysis of new monkey serotypes,
should facilitate the investigation of the importance of these
RBE expansions.
cis-acting sequences and emerging integration models. The
basis for the greater affinity of Rep for the simian RBE was
demonstrated by MI, where both AAV2 and AAV4 Rep68H
proteins specifically contacted all five GAGC tetramers, pro-
ducing a quantitatively stronger interaction than with the hu-
man RBE. The interaction was symmetrical about the RBE as
previously described (40) and demonstrated significant se-
quence contacts within the spacer element. This increased in-
teraction at the chromosome spacer may indicate the impor-
tance of Rep contact within the spacer region, as recently
indicated by the in vitro integration assay (34). In that study,
an RBE, trs, and spacer of human ch19 were present in an
Epstein-Barr virus shuttle vector, and it was demonstrated that
mutating or removing the spacer significantly decreased or
abolished integration. A developing model for Rep-ch19 inter-
action proposes that each element—the RBE, spacer, and
trs—has a particular function in AAV site-specific integration.
In summary, the number of GAGC tetramers contained in the
RBE affects the affinity of Rep and its ability to locate the
target site, while the spacer may be important in orienting the
Rep complex toward the trs.
AAV integrates site specifically, targeting the simian RBE.
Our study clearly demonstrated that the simian sequence could
serve as a locus for site-specific integration when transfection
assays were carried out with AAV plasmid integration sub-
strates. Site-specific recombination in the simian genome (us-
ing Cos-7 cells) was demonstrated using AAV2 ITR neo con-
structs with AAV4 Rep68 and AAV2 ITR puro or GFP
constructs with AAV2 Rep68. Using these substrates, we dem-
onstrated an approximately twofold increase in targeting in
Cos-7 versus HeLa cells (Table 2). Comparatively, targeting
efficiency in Cos-7 cells was consistently greater than in HeLa
cells. Additionally, the 42 and 36% targeting efficiencies in
HeLa cells are consistent with previous reports (reviewed in
reference 43). Although in this study we compared the effi-
ciency and frequency of targeting for a relatively small number
of cells (Fig. 6 and Table 2), all of the cells (HeLa and Cos-7)
were treated in an identical manner to provide the most accu-
rate comparison, and in the case of ITR-GFP constructs, there
was no drug selection; instead, cell sorting was employed to
normalize for transfection differences.
The GFP constructs were used to monitor long-term expres-
sion from the chromosomal integration locus and compared
overall (specific and nonspecific) integration frequencies me-
diated by AAV2 Rep68 without drug selection. Again, Cos-7
cells demonstrated at least a twofold-greater site-specific la-
tency than HeLa cells (4.6 versus 2.1%). This result is consis-
tent with the twofold-greater targeted (specific) latency deter-
mined by PCR analysis. Additionally, our data were reported
without compensating for the 2.7 copies of the ch19 locus in
HeLa cells. Previously, Hoggan et al. reported that 20% of
primary kidney cell lots from African green monkeys and 1 to
2% of human embryonic kidney cell lots examined were in-
fected with latent AAV (19). These observations suggest that
the frequency of wild-type AAV integration in the simian ge-
nome may be greater than in the human genome. The integra-
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tion frequency of 20% is greater than that generally reported
for wild-type AAV in culture, unless infections are performed
at very high multiplicities of infection (7, 26, 43). An additional
factor cited in producing low frequencies of targeted integra-
tion during in vitro experiments is that latent cells may be
diluted out of a culture before it is tested for the presence of
proviral AAV (43). This may affect the frequency of integra-
tion, especially at low multiplicities of infection, where the
initial number of cells infected is relatively small. In our ex-
periments, transfection efficiencies were 90%, and addition-
ally, we enriched for positive GFP-expressing cells at day 5
postinfection by sorting. Therefore, diluting out cells carrying
AAV proviral DNA appeared unlikely. We also noted a slow
decline over months in cells expressing GFP, which is incon-
sistent with the dilution of episomal templates. Cells lost flu-
orescence intensity, suggesting a low turnover rate for the GFP
protein within the cell (known half-life, 3 to 4 weeks). Regard-
less, our experiments were designed to compare relative inte-
gration frequencies in the Cos-7 and HeLa cells, and the re-
sults from these studies suggest that frequencies of integration
in both cell lines are relatively low. This is in agreement with
the results of other laboratories, which have also reported low
integration frequencies in human cell lines (3%) with recom-
binant AAV2 constructs (reviewed in reference 43). Previously
in our laboratory, low integration frequencies were also ob-
served when long-term expression from the LacZ reporter
gene was monitored in HeLa cells for 18 months (AAV2
Rep68-mediated targeting). In that study, 1% of the HeLa cells
stably expressed the LacZ gene product 70 days after transfec-
tion, and this percentage continued unchanged for the entire
18 months of the experiment (56). In the present study, we did
not have access to the AAV4 ITRs, and the integration analysis
was derived from type 2 and 4 Rep68 proteins using AAV2
ITRs. This combination may have affected the true targeting
frequency in simian cells (type 4 in Cos cells). unique
The experimental results were consistent for the three con-
structs (pDD-neo, pDD-puro, and pDD-GFP), and integration
in the simian genome was consistently twofold greater than in
the human genome. A similar relationship has been recognized
in transposon integration, where higher affinity of the trans-
posase for its DNA binding site correlates to greater targeting
frequency (29). Comparing recombinant AAV integration in
human and simian cells, other than an increased Rep binding
affinity for the expanded simian RBE, we are unaware at this
point of any mechanisms that may be contributing to the in-
crease in targeting frequency, although many other factors
(e.g., host proteins) could be at play. However, the RBE ex-
pansion in the African green monkey may make the site in-
herently more distinctive in the genome, providing more in-
formation for Rep and, we suspect, giving Rep68 a greater
functional specificity (4, 5, 54). It will be interesting to inves-
tigate the AAV integration sites in other nonhuman primates
to determine if the RBE expansion is universal in this diverse
group. In addition, testing of artificially generated targeting
loci whose RBEs, as well as other critical cis-acting elements,
vary will eventually define the importance of each of these
sequences in facilitating AAV site-specific recombination and
the future development of AAV-targeting vectors.
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